Patricia L. Kandalaft

The Human Hematopoietic Progenitor Cell Antigen (CD 3 4) in Vascular Neoplasia

S. Thomas Traweek, Patricia L. Kandalaft, Parula Mehta et al. · American Journal of Clinical Pathology · 1991 · 302 citations

Immunology, Blood Cell, Pathology +16

Routine pathologic parameters can predict Oncotype DXTM recurrence scores in subsets of ER positive patients: who does not always need testing?

Kimberly H. Allison, Patricia L. Kandalaft, Colleen M. Sitlani et al. · Breast Cancer Research and Treatment · 2011 · 126 citations

Routine Pathologic Parameters, Disease Progression, Medicine +8

Determining True <i>HER2</i> Gene Status in Breast Cancers With Polysomy by Using Alternative Chromosome 17 Reference Genes: Implications for Anti-<i>HER2</i> Targeted Therapy

Chun Hing Tse, Harry C. Hwang, Lynn C. Goldstein et al. · Journal of Clinical Oncology · 2011 · 119 citations

Vimentin-Negative Epithelioid Sarcoma

Daniel A. Arber, Patricia L. Kandalaft, Parula Mehta et al. · The American Journal of Surgical Pathology · 1993 · 105 citations

Tumoral Pathology, Focal Vimentin, Medicine +14

Practical Applications in Immunohistochemistry: Carcinomas of Unknown Primary Site

Patricia L. Kandalaft, Allen M. Gown · Archives of Pathology & Laboratory Medicine · 2015 · 105 citations